Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01284361 · ClinicalTrials.gov registry record · NA
Comparison of Two Intermittent Urinary Catheters
A NA study, sponsored by Hollister Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT01284361: Completed NA study, sponsored by Hollister Incorporated.
NCT01284361 is a NA study that has completed, run by Hollister Incorporated. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01284361, a NA study, has completed, sponsored by Hollister Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
This is an unblinded, multi-center, randomized, controlled, cross-over study assessing wheel-chair bound, male user preference and catheter characteristics of two intermittent urinary catheters. Subjects enrolled in the study will be randomized to order of catheter use. Individual participation will consist of approximately 1 week of product use. The null hypothesis to be tested is there no difference between catheters.
Primary Outcome
Percentage of participants that preferred the 40 cm catheter
Interventions
- DEVICE 30 cm Intermittent Catheter
- DEVICE 40 cm Intermittent Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT01284361 record still lists
NCT01284361 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which 30 cm Intermittent Catheter is the first listed.
NCT01284361 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01284361 about?
NCT01284361 is a clinical study titled "Comparison of Two Intermittent Urinary Catheters". This is an unblinded, multi-center, randomized, controlled, cross-over study assessing wheel-chair bound, male user preference and catheter characteristics of two intermittent urinary catheters. Subjects enrolled in the study will be randomized to order of catheter use. Individual participation will...
What is the current status of trial NCT01284361?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2010-10. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01284361?
The interventions under investigation include: 30 cm Intermittent Catheter (DEVICE), 40 cm Intermittent Catheter (DEVICE).
Who is sponsoring clinical trial NCT01284361?
This trial is sponsored by Hollister Incorporated, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01284361's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia